U.S. Markets open in 7 hrs 23 mins
  • S&P Futures

    3,756.25
    -33.25 (-0.88%)
     
  • Dow Futures

    30,521.00
    -260.00 (-0.84%)
     
  • Nasdaq Futures

    11,417.00
    -112.50 (-0.98%)
     
  • Russell 2000 Futures

    1,687.00
    -21.00 (-1.23%)
     
  • Crude Oil

    104.69
    -1.07 (-1.01%)
     
  • Gold

    1,797.50
    -9.80 (-0.54%)
     
  • Silver

    20.11
    -0.17 (-0.82%)
     
  • EUR/USD

    1.0470
    -0.0013 (-0.1256%)
     
  • 10-Yr Bond

    2.9720
    0.0000 (0.00%)
     
  • Vix

    28.71
    +0.55 (+1.95%)
     
  • GBP/USD

    1.2134
    -0.0041 (-0.3373%)
     
  • USD/JPY

    134.7930
    -0.9350 (-0.6889%)
     
  • BTC-USD

    19,487.61
    -499.94 (-2.50%)
     
  • CMC Crypto 200

    418.35
    -13.12 (-3.04%)
     
  • FTSE 100

    7,169.28
    -143.04 (-1.96%)
     
  • Nikkei 225

    25,959.20
    -433.84 (-1.64%)
     

CRISPR Technology Market Size to Grow by USD 2.88 billion | 44% of the growth to originate from North America | 17,000+ Technavio Reports

·13 min read

NEW YORK, May 27, 2022 /PRNewswire/ -- The CRISPR technology market potential growth difference will grow by USD 2.88 billion from 2021 to 2026, as per the latest market analysis report by Technavio. The report predicts the market to witness an accelerating growth momentum at a CAGR of 19.34% during the projected period. The increasing demand for the treatment of genetic diseases is notably driving the CRISPR technology market growth, although factors such as ethical issues associated with CRISPR technology may impede the market growth. Furthermore, the advent of CRISPR/ Cas9 is one of the key CRISPR technology market trends that is expected to impact the industry positively in the forecast period.

Technavio has announced its latest market research report titled Crispr Technology Market by Application and Geography - Forecast and Analysis 2022-2026
Technavio has announced its latest market research report titled Crispr Technology Market by Application and Geography - Forecast and Analysis 2022-2026

For more insights on CAGR and YOY growth variance, Read Our Sample Report

CRISPR Technology Market: Application Landscape

  • The CRISPR technology market is segmented by application into biological application, agricultural application, industrial application, and others. The biological application segment held the largest market share in 2021. The segment will continue to account for the highest revenue throughout the forecast period.

  • The growth of the segment is attributed to the increasing number of biomedical research studies being conducted in universities and research institutions. This is due to increasing awareness about the need for multidisciplinary and interdisciplinary genetics research studies to treat complex diseases and disorders has given a boost to biomedical research.

CRISPR Technology Market: Geography Landscape

  • 44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for CRISPR technology in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

  • The increasing spending on research, the presence of biotechnology companies and vendors that offer gene-editing services, and the high focus on biomedical research by universities and research institutions will facilitate the CRISPR technology market growth in North America over the forecast period.

Download Sample Report for Insights on each contributing segment

CRISPR Technology Market: Vendor Landscape

The CRISPR technology market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Companies are launching innovative solutions to ensure their position is retained in the market. For instance, Danaher Corp. offers Alt-R CRISPR-Cas9 System, which is an optimized genome editing solution that outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.

Companies Covered:

  • Addgene Inc.

  • Agilent Technologies Inc.

  • Applied StemCell Inc.

  • Caribou Biosciences Inc.

  • Cellecta Inc.

  • CRISPR Therapeutics AG

  • Danaher Corp.

  • Editas Medicine Inc.

  • GeneCopoeia Inc.

  • GenScript Biotech Corp.

  • Intellia Therapeutics Inc.

  • Lonza Group Ltd.

  • Merck KGaA

  • Mirus Bio LLC

  • New England Biolabs Inc.

  • Novartis AG

  • OriGene Technologies Inc.

  • PerkinElmer Inc.

  • Synthego Corp.

  • Thermo Fisher Scientific Inc.

Download Report Sample for more insights on each vendor and their product offerings

What our reports offer:

  • Market share assessments for the regional and country-level segments

  • Strategic recommendations for the new entrants

  • Covers market data for 2020, 2021, until 2026

  • Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)

  • Strategic recommendations in key business segments based on the market estimations

  • Competitive landscaping mapping the key common trends

  • Company profiling with detailed strategies, financials, and recent developments

  • Supply chain trends mapping the latest technological advancements

Related Reports:

Seborrheic Keratosis Treatment Market by Application and Geography - Forecast and Analysis 2022-2026

Multiplex Assays Market by Type and Geography - Forecast and Analysis 2022-2026

CRISPR Technology Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 19.34%

Market growth 2022-2026

$ 2.88 billion

Market structure

Fragmented

YoY growth (%)

18.25

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key consumer countries

US, Canada, UK, Germany, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Addgene Inc., Agilent Technologies Inc., Applied StemCell Inc., Caribou Biosciences Inc., Cellecta Inc., CRISPR Therapeutics AG, Danaher Corp., Editas Medicine Inc., GeneCopoeia Inc., GenScript Biotech Corp., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, New England Biolabs Inc., Novartis AG, OriGene Technologies Inc., PerkinElmer Inc., Synthego Corp., and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Content

1 Executive Summary

  • 1.1 Market overview

2 Market Landscape

  • 2.1 Market ecosystem

3 Market Sizing

  • 3.1 Market definition

  • 3.2 Market segment analysis

  • 3.3 Market size 2021

  • 3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

  • 4.1 Five forces summary

  • 4.2 Bargaining power of buyers

  • 4.3 Bargaining power of suppliers

  • 4.4 Threat of new entrants

  • 4.5 Threat of substitutes

  • 4.6 Threat of rivalry

  • 4.7 Market condition

5 Market Segmentation by Application

  • 5.1 Market segments

  • 5.2 Comparison by Application

  • 5.3 Biological application - Market size and forecast 2021-2026

  • 5.4 Agricultural application - Market size and forecast 2021-2026

  • 5.5 Industrial application - Market size and forecast 2021-2026

  • 5.6 Others - Market size and forecast 2021-2026

  • 5.7 Market opportunity by Application

6 Customer Landscape

  • 6.1 Customer landscape overview

7 Geographic Landscape

  • 7.1 Geographic segmentation

  • 7.2 Geographic comparison

  • 7.3 North America - Market size and forecast 2021-2026

  • 7.4 Europe - Market size and forecast 2021-2026

  • 7.5 Asia - Market size and forecast 2021-2026

  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026

  • 7.7 US - Market size and forecast 2021-2026

  • 7.8 UK - Market size and forecast 2021-2026

  • 7.9 Canada - Market size and forecast 2021-2026

  • 7.10 Germany - Market size and forecast 2021-2026

  • 7.11 Japan - Market size and forecast 2021-2026

  • 7.12 Market opportunity by geography

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers

  • 8.2 Market challenges

  • 8.3 Impact of drivers and challenges

  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview

  • 9.2 Vendor landscape

  • 9.3 Landscape disruption

  • 9.4 Industry risks

10 Vendor Analysis

  • 10.1 Vendors covered

  • 10.2 Market positioning of vendors

  • 10.3 Danaher Corp.

  • 10.4 Editas Medicine Inc.

  • 10.5 GeneCopoeia Inc.

  • 10.6 GenScript Biotech Corp.

  • 10.7 Intellia Therapeutics Inc.

  • 10.8 Lonza Group Ltd.

  • 10.9 New England Biolabs Inc.

  • 10.10 OriGene Technologies Inc.

  • 10.11 PerkinElmer Inc.

  • 10.12 Thermo Fisher Scientific Inc.

11 Appendix

  • 11.1 Scope of the report

  • 11.2 Inclusions and exclusions checklist

  • 11.3 Currency conversion rates for US$

  • 11.4 Research methodology

  • 11.5 List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)
Technavio (PRNewsfoto/Technavio)
Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/crispr-technology-market-size-to-grow-by-usd-2-88-billion--44-of-the-growth-to-originate-from-north-america--17-000-technavio-reports-301555769.html

SOURCE Technavio